These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 21216643)

  • 1. The effect of blood phenylalanine concentration on Kuvan™ response in phenylketonuria.
    Elsas LJ; Greto J; Wierenga A
    Mol Genet Metab; 2011 Apr; 102(4):407-12. PubMed ID: 21216643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of tetrahydrobiopterin (BH(4))-responsiveness and spontaneous phenylalanine reduction in a phenylalanine hydroxylase deficiency population.
    Tansek MZ; Groselj U; Murko S; Kobe H; Lampret BR; Battelino T
    Mol Genet Metab; 2012 Sep; 107(1-2):37-42. PubMed ID: 22917871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of patients with phenylketonuria in the US to tetrahydrobiopterin.
    Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unresponsiveness to tetrahydrobiopterin of phenylalanine hydroxylase deficiency.
    Ponzone A; Porta F; Mussa A; Alluto A; Ferraris S; Spada M
    Metabolism; 2010 May; 59(5):645-52. PubMed ID: 19913839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of extended treatment with sapropterin dihydrochloride in patients with phenylketonuria: results of a phase 3b study.
    Burton BK; Nowacka M; Hennermann JB; Lipson M; Grange DK; Chakrapani A; Trefz F; Dorenbaum A; Imperiale M; Kim SS; Fernhoff PM
    Mol Genet Metab; 2011 Aug; 103(4):315-22. PubMed ID: 21646032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized loading test to evaluate responsiveness to tetrahydrobiopterin (BH4) in Brazilian patients with phenylalanine hydroxylase deficiency.
    Nalin T; Perry ID; Sitta A; Vargas CR; Saraiva-Pereira ML; Giugliani R; Blau N; Schwartz IV
    Mol Genet Metab; 2011; 104 Suppl():S80-5. PubMed ID: 22014474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin.
    Dobrowolski SF; Borski K; Ellingson CC; Koch R; Levy HL; Naylor EW
    J Hum Genet; 2009 Jun; 54(6):335-9. PubMed ID: 19444284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing the use of sapropterin (BH(4)) in the management of phenylketonuria.
    Blau N; Bélanger-Quintana A; Demirkol M; Feillet F; Giovannini M; MacDonald A; Trefz FK; van Spronsen FJ
    Mol Genet Metab; 2009 Apr; 96(4):158-63. PubMed ID: 19208488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized long-term outcomes in blood phenylalanine concentrations and dietary phenylalanine tolerance in 11 patients with primary phenylalanine hydroxylase (PAH) deficiency treated with Sapropterin-dihydrochloride.
    Stockler-Ipsiroglu S; Yuskiv N; Salvarinova R; Apatean D; Ho G; Cheng B; Giezen A; Lillquist Y; Ueda K
    Mol Genet Metab; 2015 Mar; 114(3):409-14. PubMed ID: 25497838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population.
    Dobrowolski SF; Heintz C; Miller T; Ellingson C; Ellingson C; Ozer I; Gökçay G; Baykal T; Thöny B; Demirkol M; Blau N
    Mol Genet Metab; 2011 Feb; 102(2):116-21. PubMed ID: 21147011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of phenylalanine hydroxylase genotype for tetrahydrobiopterin responsiveness classification in patients with phenylketonuria.
    Quirk ME; Dobrowolski SF; Nelson BE; Coffee B; Singh RH
    Mol Genet Metab; 2012 Sep; 107(1-2):31-6. PubMed ID: 22841515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study.
    Fiege B; Bonafé L; Ballhausen D; Baumgartner M; Thöny B; Meili D; Fiori L; Giovannini M; Blau N
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S91-5. PubMed ID: 16290003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
    Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
    Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sapropterin dihydrochloride (Kuvan/phenoptin), an orally active synthetic form of BH4 for the treatment of phenylketonuria.
    Burnett JR
    IDrugs; 2007 Nov; 10(11):805-13. PubMed ID: 17968763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.
    Lagler FB; Gersting SW; Zsifkovits C; Steinbacher A; Eichinger A; Danecka MK; Staudigl M; Fingerhut R; Glossmann H; Muntau AC
    Biochem Pharmacol; 2010 Nov; 80(10):1563-71. PubMed ID: 20705059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluctuations in phenylalanine concentrations in phenylketonuria: a review of possible relationships with outcomes.
    Cleary M; Trefz F; Muntau AC; Feillet F; van Spronsen FJ; Burlina A; Bélanger-Quintana A; Giżewska M; Gasteyger C; Bettiol E; Blau N; MacDonald A
    Mol Genet Metab; 2013 Dec; 110(4):418-23. PubMed ID: 24090706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tetrahydrobiopterin on Phe/Tyr ratios and variation in Phe levels in tetrahydrobiopterin responsive PKU patients.
    Humphrey M; Nation J; Francis I; Boneh A
    Mol Genet Metab; 2011; 104(1-2):89-92. PubMed ID: 21624843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of BH(4) supplementation on phenylalanine tolerance.
    Burlina A; Blau N
    J Inherit Metab Dis; 2009 Feb; 32(1):40-5. PubMed ID: 19067227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria.
    Hennermann JB; Bührer C; Blau N; Vetter B; Mönch E
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S86-90. PubMed ID: 16051511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment and diagnosis of tetrahydrobiopterin-responsive hyperphenylalaninemia with a mutant phenylalanine hydroxylase gene.
    Shintaku H; Kure S; Ohura T; Okano Y; Ohwada M; Sugiyama N; Sakura N; Yoshida I; Yoshino M; Matsubara Y; Suzuki K; Aoki K; Kitagawa T
    Pediatr Res; 2004 Mar; 55(3):425-30. PubMed ID: 14681498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.